
Journal of Medicinal Chemistry p. 2662 - 2665 (2002)
Update date:2022-08-05
Topics:
Ronsisvalle, Giuseppe
Prezzavento, Orazio
Marrazzo, Agostino
Vittorio, Franco
Massimino, Michele
Murari, Giovanna
Spampinato, Santi
(+)-cis-N-(4-isothiocyanatobenzyl)-N-normetazocine (BNIT) (+)-(4) was designed and synthesized as a derivative of the potent and selective σ1 receptor ligand (+)-cis-N-benzyl-Nnormetazocine for irreversibly blocking σ1 binding sites.
View Morewebsite:http://www.shtopchem.com/
Contact:0086-0576-87776998
Address:room no 1608,xuhui business building yude road,xujiahui street, xuhui district
NanJing KaiHeng Chemical CO., LTD.
Contact:+86-25-85768391
Address:RM.1704, D, WANDA PLAZA, NO.110, MIDDLE JIANGDONG ROAD, NANJING, CHINA
Shanghai better-in Medical Technology Co.,LTD.
Contact:+86-21-38921049
Address:Lane 720 zhangjianggaoke cailun road, Pudong, Shanghai, room 513
Contact:0510-85393305
Address:1619 Huishan Avenue, Huishan District, Wuxi,
Shanghai Forever Biotech Co., Ltd.
Contact:+86-21-69734790
Address:Room 5017/5019、5022、5024 of Technology Innovation Centre, No.1155, Gongyuan East Rd, QingPu District, Shanghai China.
Doi:10.1021/co500023k
(2014)Doi:10.1016/j.bmc.2014.03.041
(2014)Doi:10.1021/acs.orglett.6b03746
(2017)Doi:10.1021/acsmedchemlett.5b00095
(2015)Doi:10.1039/c2sm26124c
(2012)Doi:10.1016/j.ejmech.2019.111596
(2019)